Diclofenac interactions: tetrakis[mu-2-(2,6-dichloroanilino)phenylacetato]-1:2 kappa 8O:O'-diacetone-1 kappa O,2 kappa O-dicopper(II)(Cu-Cu) acetaldehyde solvate.
The structure of the centrosymmetric dimeric copper(II) title compound, [Cu2(C14H10Cl2NO2)4(C3H6O)2] C2H4O, has been determined and compared with the structures of analogous O-bridged CuII dimers. Polarographic experiments on aqueous solutions containing a mixture of the CuII ion and diclofenac have been used to determine both the formation constant [1 (1) x 10(8)] and the solubility product [2 (1) x 10(-12)] of the complex.
Dipartimento di Chimica G. Ciamician, Universitá di Bologna, Italy.
C
C
Castellari
G
G
Feroci
S
S
Ottani
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry; D003300:Copper / Q000737:chemistry; D018360:Crystallography, X-Ray; D004008:Diclofenac / Q000737:chemistry*; D019281:Dimerization; D008670:Metals / Q000737:chemistry; D008958:Models, Molecular; D008968:Molecular Conformation; D015394:Molecular Structure; D009942:Organometallic Compounds / Q000737:chemistry*; D011048:Polarography; D012995:Solubility; D013329:Structure-Activity Relationship
D000894:Anti-Inflammatory Agents, Non-Steroidal; D008670:Metals; D009942:Organometallic Compounds; C120466:tetrakis(mu-2-(2,6-dichloroanilino)phenylacetato)-1-2kappa(8)O-O'-diacetone-1kappaO,2kappaO-dicopper(II)(Cu-Cu)acetaldehyde; D004008:Diclofenac; D003300:Copper